115
Views
31
CrossRef citations to date
0
Altmetric
Original Research

Nanoparticle-based strategy for personalized B-cell lymphoma therapy

, , , , , , , , & show all
Pages 6089-6101 | Published online: 16 Nov 2016

References

  • BanghamADStandishMMWatkinsalJCDiffusion of univalent ions across the lamellae of swollen phospholipidsJ Mol Biol19651312382525859039
  • LaVanDAMcGuireTLangerRSmall-scale systems for in vivo drug deliveryNat Biotechnol200321101184119114520404
  • LangerRNew methods of drug deliveryScience19902494976152715332218494
  • ShiJJXiaoZKamalyNFarokhzadOCSelf-assembled targeted nanoparticles: evolution of technologies and bench to bedside translationAcc Chem Res201144101123113421692448
  • YangYYuCAdvances in silica based nanoparticles for targeted cancer therapyNanomedicine201612231733226706409
  • SchleichNPoCJacobsDComparison of active, passive and magnetic targeting to tumors of multifunctional paclitaxel/SPIO-loaded nanoparticles for tumor imaging and therapyJ Control Release2014194829125178270
  • MitraSGaurUGhoshPCMaitraANTumour targeted delivery of encapsulated dextran-doxorubicin conjugate using chitosan nanoparticles as carrierJ Control Release2001741–331732311489513
  • SteichenSDCaldorera-MooreMPeppasNAA review of current nanoparticle and targeting moieties for the delivery of cancer therapeuticsEur J Pharm Sci201348341642723262059
  • WangXLiSShiYThe development of site-specific drug delivery nanocarriers based on receptor mediationJ Control Release201419313915324862317
  • ThomsenLBThomsenMSMoosTTargeted drug delivery to the brain using magnetic nanoparticlesTher Deliv20156101145115526446407
  • XiongLBiJTangYQiaoSZMagnetic core-shell silica nanoparticles with large radial mesopores for siRNA deliverySmall201612344735474227199216
  • DavisMEZuckermanJEChoiCHEvidence of RNAi in humans from systemically administered siRNA via targeted nanoparticlesNature201046472911067107020305636
  • VarshosazJFarzanMNanoparticles for targeted delivery of therapeutics and small interfering RNAs in hepatocellular carcinomaWorld J Gastroenterol20152142120221204126576089
  • BarretoJAO’ MalleyWKubeilMGrahamBStephanHSpicciaLNanomaterials: applications in cancer imaging and therapyAdv Mater20112312H18H4021433100
  • ArgyoCWeissVBräuchleCBeinTMultifunctional mesoporous silica nanoparticles as a universal platform for drug deliveryChem Mater2014261435451
  • Vivero-EscotoJLSlowingIITrewynBGLinVSMesoporous silica nanoparticles for intracellular controlled drug deliverySmall20106181952196720690133
  • ReaIMartucciNMDe StefanoLDiatomite biosilica nanocarriers for siRNA transport inside cancer cellsBiochim Biophys Acta20141840123393340325224732
  • RuggieroITerraccianoMMartucciNMDiatomite silica nanoparticles for drug deliveryNanoscale Res Lett20149132933525024689
  • TerraccianoMShahbaziMACorreiaASurface bioengineering of diatomite based nanovectors for efficient intracellular uptake and drug deliveryNanoscale2015747200632007426568517
  • ZhangHShahbaziMAMäkiläEMDiatom silica microparticles for sustained release and permeation enhancement following oral delivery of prednisone and mesalamineBiomaterials201334369210921924008036
  • MigkouMDimopoulosMAGavriatopoulouMTerposEApplications of monoclonal antibodies for the treatment of hematological malignanciesExpert Opin Biol Ther20099220722019236251
  • ReedJCBcl-2-family proteins and hematologic malignancies: history and future prospectsBlood200811173322333018362212
  • Chanan-KhanABcl-2 antisense therapy in B-cell malignanciesBlood Rev200519421322115784299
  • AbdullahLNChowEK-HMechanisms of chemoresistance in cancer stem cellsClin Transl Med20132131123369605
  • BanerjeeAQianPWuZ-SArtemin stimulates radio- and chemo-resistance by promoting TWIST1-BCL-2-dependent cancer stem cell like behavior in mammary carcinoma cellsJ Biol Chem201228751425024251523095743
  • EbrahimASSabbaghHLiddaneARaufiAKandouzMAl-KatibAHematologic malignancies: newer strategies to counter the BCL-2 proteinJ Cancer Res Clin Oncol201614292013202227043233
  • O’ BrienSMooreJOBoydTERandomized phase III trial of fludarabine plus cyclophosphamide with or without oblimersen sodium (Bcl-2 antisense) in patients with relapsed or refractory chronic lymphocytic leukemiaJ Clin Oncol20072591114112017296974
  • CotterFEWatersJCunninghamDHuman Bcl-2 antisense therapy for lymphomasBiochim Biophys Acta1999148919710610807000
  • PalmieriCFalconeCIaccinoEIn vivo targeting and growth inhibition of the A20 murine B-cell lymphoma by an idiotype-specific peptide binderBlood2010116222623820363775
  • MigliaccioNPalmieriCRuggieroIB-cell receptor-guided delivery of peptide-siRNA complex for B-cell lymphoma therapyCancer Cell Int201515505825983658
  • WangYHuangHYYangLZhangZJiHCetuximab-modified mesoporous silica nano-medicine specifically targets EGFR-mutant lung cancer and overcomes drug resistanceSci Rep20166254682547727151505
  • De StefanoLOlivieroGAmatoJAminosilane functionalizations of mesoporous oxidized silicon for oligonucleotide synthesis and detectionJ R Soc Interface201310832013016023536541
  • TerraccianoMReaIPolitiJDe StefanoLOptical characterization of aminosilane-modified silicon dioxide surface for biosensingJ Eur Opt Soc Rapid Publ201381303
  • KimKJKanellopoulos-LangevinCMerwinRMSachsDHAsofskyREstablishment and characterization of BALB/c lymphoma lines with B cell propertiesJ Immunol19791222549554310843
  • SpatuzzaCSchiavoneMDi SalleEPhysical and functional characterization of the genetic locus of IBtk, an inhibitor of Bruton’s tyrosine kinase: evidence for three protein isoforms of IBtkNucleic Acids Res200836134402441618596081
  • BradfordMMA rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnal Biochem1976721248254942051
  • SanOGörenRÖzgürCPurification of diatomite powder by acid leaching for use in fabrication of porous ceramicsInt J Mine Process2009931610
  • MartucciNMReaIRuggieroIA new strategy for label-free detection of lymphoma cancer cellsBiomed Opt Express2015641353136225909019
  • De AngelisFPujiaAFalconeCWater soluble nanoporous nanoparticle for in vivo targeted drug delivery and controlled release in B cells tumor contextNanoscale20102102230223620835434
  • LoikeJDSilversteinSCA fluorescence quenching technique using trypan blue to differentiate between attached and ingested glutaraldehyde-fixed red blood cells in phagocytosing murine macrophagesJ Immunol Methods1983571–33733796402550
  • KouLSunJZhaiYHeZThe endocytosis and intracellular fate of nanomedicines: implication for rational designAsian J Pharmaceut Sci201381110
  • BannunahAMVllasaliuDLordJStolnikSMechanisms of nanoparticle internalization and transport across an intestinal epithelial cell model: effect of size and surface chargeMol Pharm201411124363437325327847
  • VecchioneRLucianiGCalcagnoVMultilayered silicabiopolymer nanocapsules with a hydrophobic core and a hydrophilic tunable shell thicknessNanoscale20168168798880927065306
  • LoveSAMaurer-JonesMAThompsonJWLinYHaynesCLAssessing nanoparticle toxicityAnnu Rev Anal Chem20125181205
  • RosenholmJMMeinanderAPeuhuETargeting of porous hybrid silica nanoparticles to cancer cellsACS Nano20093119720619206267
  • LuJLiongMLiZZinkJITamanoiFBiocompatibility, biodistribution, and drug-delivery efficiency of mesoporous silica nanoparticles for cancer therapy in animalsSmall20106161794180520623530
  • VarnaMRatajczakPFerreiraILeboeufCBousquetGJaninAIn vivo distribution of inorganic nanoparticles in preclinical modelsJ Biomater Nanobiotechnol201232A269279
  • ScarfòLGhiaPReprogramming cell death: BCL2 family inhibition in hematological malignanciesImmunol Lett20131551–2363924095849
  • Garcıa-SaezAJThe secrets of the Bcl-2 familyCell Death Differ2012191733174022935609
  • DingLHuXMWuHCombined transfection of Bcl-2 siRNA and miR-15a oligonucleotides enhanced methotrexate-induced apoptosis in Raji cellsCancer Biol Med2013101162123691440
  • HatakeyamaHItoEAkitaHA pH-sensitive fusogenic peptide facilitates endosomal escape and greatly enhances the gene silencing of siRNA-containing nanoparticles in vitro and in vivoJ Control Release2009139212713219540888
  • MinakuchiYTakeshitaFKosakaNAtelocollagen-mediated synthetic small interfering RNA delivery for effective gene silencing in vitro and in vivoNucleic Acids Res20043213e10915272050
  • HeDFangBSmall hairpin RNA targeting at Bcl-2 increases cytarabine induced apoptosis in Raji cellsActa Biochim Biophys Sin (Shanghai)200941213113619204830
  • NagamatsuKTsuchiyaFOgumaKMaruyamaHKanoRHasegawaAThe effect of small interfering RNA (siRNA) against the Bcl-2 gene on apoptosis and chemosensitivity in a canine mammary gland tumor cell lineRes Vet Sci2008841495517537469